(+)-schisandrin B increases expression EXP 6480464 schizandrin B results in increased expression of HSPA9 protein CTD PMID:21616119 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA9 mRNA] CTD PMID:31150632 (-)-anisomycin multiple interactions EXP 6480464 Anisomycin inhibits the reaction [Cocaine results in increased expression of HSPA9 protein] CTD PMID:12422371 (1->4)-beta-D-glucan multiple interactions ISO RGD:1323452 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSPA9 mRNA CTD PMID:36331819 (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:1323451 6480464 CAT protein inhibits the reaction [27-hydroxycholesterol results in increased expression of HSPA9 protein] more ... CTD PMID:33880675 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:1323451 6480464 27-hydroxycholesterol results in increased expression of HSPA9 protein CTD PMID:33880675 (R)-adrenaline multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 1,2-dimethylhydrazine multiple interactions ISO RGD:1323452 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1323452 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of HSPA9 mRNA CTD PMID:20551477 1-naphthyl isothiocyanate multiple interactions ISO RGD:1323451 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSPA9 mRNA CTD PMID:27344345 17alpha-ethynylestradiol increases expression ISO RGD:1323452 6480464 Ethinyl Estradiol results in increased expression of HSPA9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1323452 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA9 mRNA CTD PMID:17942748 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of HSPA9 mRNA CTD PMID:32145629 1H-pyrazole increases expression ISO RGD:1323452 6480464 pyrazole results in increased expression of HSPA9 mRNA CTD PMID:17945193 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA9 protein] CTD PMID:19634143 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:1323452 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1323452 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA9 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323451 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA9 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323452 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA9 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1323452 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA9 mRNA CTD PMID:17942748 , PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323452 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:20159946 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323451 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:16039398 2,4,6-tribromophenol decreases expression ISO RGD:1323451 6480464 2 more ... CTD PMID:31675489 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1323452 6480464 2 more ... CTD PMID:16451863 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:1323452 6480464 2 more ... CTD PMID:18550172 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:1323452 6480464 Butylated Hydroxytoluene results in increased expression of HSPA9 mRNA CTD PMID:19925653 2-hydroxypropanoic acid increases expression ISO RGD:1323451 6480464 Lactic Acid results in increased expression of HSPA9 mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of HSPA9 mRNA CTD PMID:15890375 26-hydroxycholesterol multiple interactions ISO RGD:1323451 6480464 CAT protein inhibits the reaction [27-hydroxycholesterol results in increased expression of HSPA9 protein] more ... CTD PMID:33880675 26-hydroxycholesterol increases expression ISO RGD:1323451 6480464 27-hydroxycholesterol results in increased expression of HSPA9 protein CTD PMID:33880675 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1323452 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of HSPA9 protein, alpha-Chlorohydrin results in decreased expression of HSPA9 protein CTD PMID:26597043 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of HSPA9 protein CTD PMID:26072098 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1323451 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of HSPA9 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane affects expression ISO RGD:1323452 6480464 4, 4'-diaminodiphenylmethane affects the expression of HSPA9 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1323451 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HSPA9 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA9 mRNA CTD PMID:36041667 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPA9 mRNA CTD PMID:15890375 4-hydroxynon-2-enal affects binding ISO RGD:1323451 6480464 4-hydroxy-2-nonenal analog binds to HSPA9 CTD PMID:18232660 5-aza-2'-deoxycytidine increases response to substance ISO RGD:1323451 6480464 HSPA9 protein results in increased susceptibility to Decitabine CTD PMID:17389721 5-aza-2'-deoxycytidine increases expression ISO RGD:1323451 6480464 Decitabine results in increased expression of HSPA9 protein CTD PMID:19294695 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1323451 6480464 HSPA9 protein promotes the reaction [Decitabine results in increased expression of CDKN2A protein] CTD PMID:17389721 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HSPA9 mRNA CTD PMID:22504374 , PMID:30047161 7H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of HSPA9 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1323451 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA9 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1323451 6480464 Acrylamide results in increased expression of HSPA9 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of HSPA9 mRNA CTD PMID:15890375 aldehydo-D-glucose multiple interactions ISO RGD:1323451 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 aldehydo-D-glucose multiple interactions EXP 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 aldehydo-D-glucose increases expression ISO RGD:1323451 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 all-trans-retinoic acid decreases expression ISO RGD:1323451 6480464 Tretinoin results in decreased expression of HSPA9 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1323451 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA9 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of HSPA9 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HSPA9 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of HSPA9 mRNA CTD PMID:12420312 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1323451 6480464 [sodium arsenite co-treated with pyrazolanthrone] promotes the reaction [HSPA9 protein binds to TP53 protein modified form] CTD PMID:22706169 aristolochic acid A decreases expression ISO RGD:1323451 6480464 aristolochic acid I results in decreased expression of HSPA9 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1323451 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of HSPA9 mRNA CTD PMID:17851650 Aroclor 1254 decreases expression ISO RGD:1323452 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HSPA9 mRNA CTD PMID:23650126 arsane increases expression ISO RGD:1323451 6480464 Arsenic results in increased expression of HSPA9 protein CTD PMID:19818359 arsane affects expression ISO RGD:1323451 6480464 Arsenic affects the expression of HSPA9 mRNA CTD PMID:18414638 arsenic atom affects expression ISO RGD:1323451 6480464 Arsenic affects the expression of HSPA9 mRNA CTD PMID:18414638 arsenic atom increases expression ISO RGD:1323451 6480464 Arsenic results in increased expression of HSPA9 protein CTD PMID:19818359 arsenite(3-) multiple interactions ISO RGD:1323451 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [arsenite results in increased expression of HSPA9 mRNA] more ... CTD PMID:20199942 arsenite(3-) increases expression ISO RGD:1323451 6480464 arsenite results in increased expression of HSPA9 mRNA, arsenite results in increased expression of HSPA9 protein CTD PMID:20199942 arsenous acid increases expression ISO RGD:1323452 6480464 Arsenic Trioxide results in increased expression of HSPA9 protein CTD PMID:27638049 arsenous acid multiple interactions ISO RGD:1323452 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein] CTD PMID:27638049 atrazine decreases expression ISO RGD:1323451 6480464 Atrazine results in decreased expression of HSPA9 mRNA CTD PMID:22378314 benzo[a]pyrene multiple interactions ISO RGD:1323452 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HSPA9 mRNA] CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1323451 6480464 Benzo(a)pyrene results in increased methylation of HSPA9 promoter CTD PMID:27901495 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of HSPA9 mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of HSPA9 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSPA9 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA9 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:1323451 6480464 bisphenol A results in decreased expression of HSPA9 protein CTD PMID:31675489 , PMID:34186270 bisphenol A decreases expression ISO RGD:1323452 6480464 bisphenol A results in decreased expression of HSPA9 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:1323451 6480464 bisphenol A results in increased expression of HSPA9 mRNA CTD PMID:33670352 bisphenol A affects expression ISO RGD:1323451 6480464 bisphenol A affects the expression of HSPA9 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1323451 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:1323451 6480464 bisphenol B results in increased expression of HSPA9 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA9 mRNA CTD PMID:36041667 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of HSPA9 protein CTD PMID:28903499 cadmium atom multiple interactions ISO RGD:1323451 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA9 protein CTD PMID:33040242 cadmium dichloride multiple interactions ISO RGD:1323451 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA9 protein CTD PMID:33040242 cadmium dichloride increases expression ISO RGD:1323451 6480464 Cadmium Chloride results in increased expression of HSPA9 protein CTD PMID:24527689 cadmium dichloride affects expression ISO RGD:1323451 6480464 Cadmium Chloride affects the expression of HSPA9 mRNA CTD PMID:23828170 caffeine decreases expression ISO RGD:1323451 6480464 Caffeine results in decreased expression of HSPA9 protein CTD PMID:31195006 calcium atom increases abundance EXP 6480464 HSPA9 protein results in increased abundance of Calcium CTD PMID:34308505 calcium(0) increases abundance EXP 6480464 HSPA9 protein results in increased abundance of Calcium CTD PMID:34308505 carbon nanotube increases expression ISO RGD:1323452 6480464 Nanotubes, Carbon results in increased expression of HSPA9 mRNA CTD PMID:25554681 casticin decreases expression ISO RGD:1323452 6480464 casticin results in decreased expression of HSPA9 mRNA CTD PMID:28444820 chloropicrin affects expression ISO RGD:1323451 6480464 chloropicrin affects the expression of HSPA9 mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of HSPA9 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1323452 6480464 Chlorpyrifos results in decreased expression of HSPA9 mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:1323452 6480464 chromium hexavalent ion affects the expression of HSPA9 mRNA CTD PMID:28472532 cisplatin decreases response to substance ISO RGD:1323451 6480464 HSPA9 protein results in decreased susceptibility to Cisplatin CTD PMID:21496427 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of HSPA9 protein CTD PMID:16470657 clofibrate increases expression ISO RGD:1323452 6480464 Clofibrate results in increased expression of HSPA9 mRNA CTD PMID:23811191 clozapine decreases expression ISO RGD:1323451 6480464 Clozapine results in decreased expression of HSPA9 protein CTD PMID:34122009 cobalt dichloride increases expression ISO RGD:1323451 6480464 cobaltous chloride results in increased expression of HSPA9 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of HSPA9 mRNA CTD PMID:24386269 cocaine multiple interactions EXP 6480464 Anisomycin inhibits the reaction [Cocaine results in increased expression of HSPA9 protein] CTD PMID:12422371 cocaine increases expression EXP 6480464 Cocaine results in increased expression of HSPA9 protein CTD PMID:12422371 copper atom multiple interactions ISO RGD:1323452 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1323452 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA CTD PMID:15467011 copper(II) chloride decreases expression ISO RGD:1323452 6480464 cupric chloride results in decreased expression of HSPA9 protein CTD PMID:29617964 copper(II) sulfate increases expression ISO RGD:1323451 6480464 Copper Sulfate results in increased expression of HSPA9 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1323451 6480464 Coumestrol results in increased expression of HSPA9 mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO RGD:1323451 6480464 cupric oxide results in decreased expression of HSPA9 protein CTD PMID:25470785 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of HSPA9 mRNA CTD PMID:11906922 cyclosporin A multiple interactions ISO RGD:1323451 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of HSPA9 mRNA CTD PMID:27344345 cyclosporin A increases expression ISO RGD:1323451 6480464 Cyclosporine results in increased expression of HSPA9 mRNA CTD PMID:20106945 more ... D-glucose multiple interactions ISO RGD:1323451 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 D-glucose multiple interactions EXP 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 D-glucose increases expression ISO RGD:1323451 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 decabromodiphenyl ether increases expression ISO RGD:1323451 6480464 decabromobiphenyl ether results in increased expression of HSPA9 protein CTD PMID:31675489 desferrioxamine B multiple interactions ISO RGD:1323451 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA CTD PMID:12393473 dexamethasone multiple interactions ISO RGD:1323451 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 diallyl trisulfide decreases expression ISO RGD:1323451 6480464 diallyl trisulfide results in decreased expression of HSPA9 protein CTD PMID:19550292 diarsenic trioxide multiple interactions ISO RGD:1323452 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein] CTD PMID:27638049 diarsenic trioxide increases expression ISO RGD:1323452 6480464 Arsenic Trioxide results in increased expression of HSPA9 protein CTD PMID:27638049 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of HSPA9 mRNA CTD PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of HSPA9 mRNA CTD PMID:22546817 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of HSPA9 mRNA CTD PMID:15890375 diethylstilbestrol increases expression ISO RGD:1323452 6480464 Diethylstilbestrol results in increased expression of HSPA9 mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:1323452 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA9 mRNA CTD PMID:30529165 disodium selenite increases expression ISO RGD:1323451 6480464 Sodium Selenite results in increased expression of HSPA9 mRNA CTD PMID:18175754 dopamine increases expression ISO RGD:1323451 6480464 Dopamine results in increased expression of HSPA9 protein CTD PMID:24675778 dorsomorphin multiple interactions ISO RGD:1323451 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1323451 6480464 Doxorubicin results in increased expression of HSPA9 mRNA CTD PMID:17680992 , PMID:29803840 efavirenz multiple interactions ISO RGD:1323451 6480464 efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 elemental selenium decreases expression ISO RGD:1323451 6480464 Selenium results in decreased expression of HSPA9 mRNA CTD PMID:19244175 elemental selenium multiple interactions ISO RGD:1323451 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HSPA9 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1323451 6480464 entinostat results in increased expression of HSPA9 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1323451 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA9 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1323451 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSPA9 protein CTD PMID:23301498 fenofibrate increases expression ISO RGD:1323452 6480464 Fenofibrate results in increased expression of HSPA9 mRNA CTD PMID:21318169 fenofibrate multiple interactions ISO RGD:1323452 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of HSPA9 mRNA] CTD PMID:21318169 fenthion decreases expression ISO RGD:1323452 6480464 Fenthion results in decreased expression of HSPA9 mRNA CTD PMID:34813904 ferric ammonium citrate multiple interactions ISO RGD:1323451 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HSPA9 mRNA CTD PMID:12393473 finasteride increases expression EXP 6480464 Finasteride results in increased expression of HSPA9 mRNA CTD PMID:24136188 flufenoxuron increases expression ISO RGD:1323452 6480464 flufenoxuron results in increased expression of HSPA9 protein CTD PMID:33771252 fluorescein 5-isothiocyanate affects binding ISO RGD:1323451 6480464 Fluorescein-5-isothiocyanate binds to HSPA9 protein CTD PMID:27129696 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HSPA9 mRNA CTD PMID:24136188 folic acid affects expression EXP 6480464 Folic Acid affects the expression of HSPA9 protein CTD PMID:16251605 folic acid multiple interactions ISO RGD:1323452 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA] CTD PMID:22206623 genistein multiple interactions ISO RGD:1323451 6480464 ESR2 promotes the reaction [Genistein results in increased expression of HSPA9 protein] CTD PMID:20884965 genistein increases expression ISO RGD:1323451 6480464 Genistein results in increased expression of HSPA9 protein CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HSPA9 mRNA CTD PMID:22061828 , PMID:33387578 glucose multiple interactions ISO RGD:1323451 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 glucose decreases expression EXP 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 glucose multiple interactions EXP 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 glucose increases expression ISO RGD:1323451 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 gold atom multiple interactions ISO RGD:1323452 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:1323452 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA CTD PMID:19695318 hemin multiple interactions ISO RGD:1323451 6480464 [Hemin results in increased abundance of Iron] which results in increased expression of HSPA9 mRNA CTD PMID:12393473 homocysteine multiple interactions ISO RGD:1323451 6480464 Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein], Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] CTD PMID:33751715 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of HSPA9 protein CTD PMID:15370871 indirubin-3'-monoxime multiple interactions ISO RGD:1323451 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA CTD PMID:18958680 indirubin-3'-monoxime increases expression ISO RGD:1323451 6480464 indirubin-3'-monoxime results in increased expression of HSPA9 mRNA CTD PMID:18958680 indometacin multiple interactions ISO RGD:1323451 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 iron atom multiple interactions ISO RGD:1323451 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA more ... CTD PMID:12393473 iron(0) multiple interactions ISO RGD:1323451 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA more ... CTD PMID:12393473 isotretinoin decreases expression ISO RGD:1323451 6480464 Isotretinoin results in decreased expression of HSPA9 mRNA CTD PMID:20436886 ivermectin increases expression ISO RGD:1323452 6480464 Ivermectin results in increased expression of HSPA9 mRNA CTD PMID:28942281 ivermectin decreases expression ISO RGD:1323451 6480464 Ivermectin results in decreased expression of HSPA9 protein CTD PMID:32959892 ivermectin increases expression ISO RGD:1323451 6480464 Ivermectin results in increased expression of HSPA9 mRNA CTD PMID:28942281 L-ascorbic acid decreases expression ISO RGD:1323451 6480464 Ascorbic Acid results in decreased expression of HSPA9 mRNA CTD PMID:19197388 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of HSPA9 mRNA CTD PMID:11578147 lead nitrate multiple interactions EXP 6480464 Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 mRNA], Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 protein] CTD PMID:24987671 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of HSPA9 mRNA, lead nitrate results in increased expression of HSPA9 protein CTD PMID:24987671 lead(II) chloride decreases expression ISO RGD:1323451 6480464 lead chloride results in decreased expression of HSPA9 protein CTD PMID:24419708 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 lithium atom increases expression EXP 6480464 Lithium results in increased expression of HSPA9 protein CTD PMID:18296634 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of HSPA9 protein CTD PMID:18296634 melatonin multiple interactions EXP 6480464 Melatonin affects the reaction [Mercuric Chloride results in increased expression of HSPA9 protein] CTD PMID:16801527 mercury dichloride multiple interactions EXP 6480464 [Mercuric Chloride co-treated with bimoclomol] affects the localization of HSPA9 protein, Melatonin affects the reaction [Mercuric Chloride results in increased expression of HSPA9 protein] CTD PMID:16801527 , PMID:16891066 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of HSPA9 protein CTD PMID:15375764 more ... metformin multiple interactions ISO RGD:1323451 6480464 Metformin inhibits the reaction [INS protein results in decreased expression of HSPA9 protein] CTD PMID:36764371 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA], Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of HSPA9 mRNA CTD PMID:19149911 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of HSPA9 mRNA CTD PMID:15890375 more ... methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of HSPA9 protein CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of HSPA9 mRNA CTD PMID:22504374 , PMID:30047161 methylmercury chloride increases expression ISO RGD:1323451 6480464 methylmercuric chloride results in increased expression of HSPA9 mRNA CTD PMID:28001369 methylparaben increases expression ISO RGD:1323451 6480464 methylparaben results in increased expression of HSPA9 mRNA CTD PMID:31745603 mevinphos increases expression EXP 6480464 Mevinphos results in increased expression of HSPA9 protein CTD PMID:17150954 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1323451 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HSPA9 mRNA] CTD PMID:12710931 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA9 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases expression ISO RGD:1323451 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA9 protein CTD PMID:24675778 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of HSPA9 mRNA CTD PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of HSPA9 protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HSPA9 mRNA CTD PMID:24136188 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of HSPA9 mRNA CTD PMID:22546817 ochratoxin A decreases expression ISO RGD:1323451 6480464 ochratoxin A results in decreased expression of HSPA9 mRNA, ochratoxin A results in decreased expression of HSPA9 protein CTD PMID:19051279 , PMID:31369848 ochratoxin A multiple interactions ISO RGD:1323451 6480464 HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein], HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] CTD PMID:31369848 ochratoxin A increases expression ISO RGD:1323451 6480464 ochratoxin A results in increased expression of HSPA9 protein CTD PMID:31369848 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of HSPA9 protein CTD PMID:31369848 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of HSPA9 protein CTD PMID:31369848 ochratoxin A multiple interactions EXP 6480464 HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein], HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] CTD PMID:31369848 ozone multiple interactions ISO RGD:1323451 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1323452 6480464 Acetaminophen affects the expression of HSPA9 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1323452 6480464 [CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of HSPA9 protein CTD PMID:25499718 paracetamol decreases expression ISO RGD:1323451 6480464 Acetaminophen results in decreased expression of HSPA9 mRNA CTD PMID:25704631 paracetamol increases expression ISO RGD:1323452 6480464 Acetaminophen results in increased expression of HSPA9 protein CTD PMID:11752693 paraquat increases expression EXP 6480464 Paraquat results in increased expression of HSPA9 mRNA CTD PMID:17935786 , PMID:32680482 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of HSPA9 protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1323452 6480464 perfluorooctane sulfonic acid affects the expression of HSPA9 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1323452 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSPA9 mRNA, perfluorooctane sulfonic acid inhibits the reaction [ITPR1 protein binds to HSPA9 protein binds to VDAC1 protein] CTD PMID:28288859 , PMID:36331819 perfluorooctanoic acid affects expression ISO RGD:1323452 6480464 perfluorooctanoic acid affects the expression of HSPA9 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HSPA9 mRNA CTD PMID:19162173 , PMID:21318169 phlorizin decreases expression ISO RGD:1323452 6480464 Phlorhizin results in decreased expression of HSPA9 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1323451 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA CTD PMID:18958680 phosgene affects expression ISO RGD:1323452 6480464 Phosgene affects the expression of HSPA9 mRNA CTD PMID:16300373 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of HSPA9 mRNA CTD PMID:15890375 pirinixic acid increases expression ISO RGD:1323452 6480464 pirinixic acid results in increased expression of HSPA9 mRNA CTD PMID:21318169 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HSPA9 mRNA CTD PMID:15890375 more ... pirinixic acid multiple interactions ISO RGD:1323452 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of HSPA9 mRNA] CTD PMID:21318169 piroxicam decreases expression ISO RGD:1323451 6480464 Piroxicam results in decreased expression of HSPA9 mRNA CTD PMID:21858171 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of HSPA9 protein CTD PMID:18563748 pterostilbene increases expression ISO RGD:1323451 6480464 pterostilbene results in increased expression of HSPA9 mRNA CTD PMID:22450950 rac-lactic acid increases expression ISO RGD:1323451 6480464 Lactic Acid results in increased expression of HSPA9 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1323451 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA9 mRNA, Resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:23557933 , PMID:24218232 resveratrol increases expression ISO RGD:1323452 6480464 resveratrol results in increased expression of HSPA9 protein CTD PMID:25505154 rotenone decreases expression ISO RGD:1323451 6480464 Rotenone results in decreased expression of HSPA9 protein CTD PMID:16565515 rotenone increases expression EXP 6480464 Rotenone results in increased expression of HSPA9 protein CTD PMID:35544339 rotenone increases expression ISO RGD:1323452 6480464 Rotenone results in increased expression of HSPA9 mRNA CTD PMID:23186747 sarin affects expression EXP 6480464 Sarin affects the expression of HSPA9 protein CTD PMID:28973502 SB 431542 multiple interactions ISO RGD:1323451 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1323451 6480464 Selenium results in decreased expression of HSPA9 mRNA CTD PMID:19244175 selenium atom multiple interactions ISO RGD:1323451 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of HSPA9 mRNA CTD PMID:19072884 sodium arsenite multiple interactions ISO RGD:1323451 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of HSPA9 protein] more ... CTD PMID:20375080 , PMID:22706169 sodium arsenite increases expression ISO RGD:1323452 6480464 sodium arsenite results in increased expression of HSPA9 mRNA CTD PMID:16014739 sodium arsenite increases expression ISO RGD:1323451 6480464 sodium arsenite results in increased expression of HSPA9 mRNA, sodium arsenite results in increased expression of HSPA9 protein CTD PMID:20375080 more ... sodium arsenite decreases expression ISO RGD:1323451 6480464 sodium arsenite results in decreased expression of HSPA9 mRNA, sodium arsenite results in decreased expression of HSPA9 protein CTD PMID:22706169 more ... sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of HSPA9 mRNA CTD PMID:12325037 sodium fluoride increases expression ISO RGD:1323452 6480464 Sodium Fluoride results in increased expression of HSPA9 protein CTD PMID:27548804 sodium fluoride decreases expression ISO RGD:1323452 6480464 Sodium Fluoride results in decreased expression of HSPA9 protein CTD PMID:27548804 Soman increases expression EXP 6480464 Soman results in increased expression of HSPA9 mRNA CTD PMID:19281266 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of HSPA9 protein CTD PMID:19634143 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA9 protein] CTD PMID:19634143 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of HSPA9 mRNA CTD PMID:30047161 sulforaphane affects binding ISO RGD:1323451 6480464 HSPA9 protein binds to sulforaphane CTD PMID:21838287 sulindac increases expression EXP 6480464 Sulindac results in increased expression of HSPA9 mRNA CTD PMID:24136188 sunitinib increases expression ISO RGD:1323451 6480464 Sunitinib results in increased expression of HSPA9 mRNA CTD PMID:31533062 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of HSPA9 protein CTD PMID:26141394 testosterone decreases expression ISO RGD:1323452 6480464 Testosterone results in decreased expression of HSPA9 mRNA CTD PMID:21669218 tetrachloroethene increases expression ISO RGD:1323452 6480464 Tetrachloroethylene results in increased expression of HSPA9 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSPA9 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1323452 6480464 Carbon Tetrachloride results in increased expression of HSPA9 mRNA CTD PMID:30538632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA9 mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1323451 6480464 Thapsigargin results in decreased expression of HSPA9 protein CTD PMID:21692457 thapsigargin increases expression ISO RGD:1323452 6480464 Thapsigargin results in increased expression of HSPA9 mRNA CTD PMID:28942281 thapsigargin increases expression ISO RGD:1323451 6480464 Thapsigargin results in increased expression of HSPA9 mRNA CTD PMID:22378314 trichostatin A decreases expression ISO RGD:1323451 6480464 trichostatin A results in decreased expression of HSPA9 protein CTD PMID:19294695 trimellitic anhydride increases expression ISO RGD:1323452 6480464 trimellitic anhydride results in increased expression of HSPA9 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1323452 6480464 troglitazone results in increased expression of HSPA9 protein CTD PMID:18495193 tunicamycin increases expression ISO RGD:1323451 6480464 Tunicamycin results in increased expression of HSPA9 mRNA CTD PMID:22378314 tunicamycin increases expression ISO RGD:1323452 6480464 Tunicamycin results in increased expression of HSPA9 mRNA CTD PMID:28942281 urethane decreases expression ISO RGD:1323451 6480464 Urethane results in decreased expression of HSPA9 mRNA CTD PMID:28818685 valproic acid multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 valproic acid multiple interactions ISO RGD:1323451 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA9 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1323451 6480464 Valproic Acid results in increased expression of HSPA9 mRNA CTD PMID:23179753 more ... valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HSPA9 mRNA CTD PMID:21318169 valproic acid affects expression ISO RGD:1323451 6480464 Valproic Acid affects the expression of HSPA9 mRNA CTD PMID:25979313 vanillic acid multiple interactions ISO RGD:1323451 6480464 Vanillic Acid inhibits the reaction [INS protein results in decreased expression of HSPA9 protein] CTD PMID:36764371 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of HSPA9 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1323451 6480464 Vitamin E results in decreased expression of HSPA9 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1323451 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1323451 6480464 vorinostat results in decreased expression of HSPA9 protein CTD PMID:20543569 withaferin A multiple interactions ISO RGD:1323451 6480464 [withaferin A inhibits the reaction [HSPA9 protein binds to TP53 protein]] which affects the localization of and results in increased activity of TP53 protein more ... CTD PMID:22973447 , PMID:25236891 withaferin A affects binding ISO RGD:1323451 6480464 withaferin A binds to HSPA9 protein CTD PMID:22973447
